Menu Close

Trending

Debates

 
Improving Outcomes Through Industry Partnership – Learnings from the Cancer Vanguard

11/06/2017

Improving Outcomes Through Industry Partnership – Learnings from the Cancer Vanguard

A unique example of partnership working across the health system, focusses on the service at large, not just the pill, and uses leading-edge data analytics to analyse, benchmark and visualise the current state of the cancer pathways within the Cancer Vanguard Trusts. Furthermore, it encompasses multiple aspects of the service provision ranging from patient outcomes and experiences, the flow of treatment and the usage of medicine in order to inform an evidence-based and patient-centric approach to service redesign and resource optimisation.

X
Improving Outcomes Through Industry Partnership – Learnings from the Cancer Vanguard
https://pharmaphorum.com/debates-insight-oncology/improving-outcomes-through-industry-partnership-learnings-from-the-cancer-vanguard/
 
Pharma and proactive, preventative healthcare: how to use the pharmacy channel

06/09/2017

Pharma and proactive, preventative healthcare: how to use the pharmacy channel

Across Europe, a shift towards greater prevention, earlier diagnosis and treatment is needed in order to contain the growing cost of healthcare. This webinar hosted by pharmaphorum with sponsor PHOENIX group looks at how harnessing the data and expertise of pharmacies, and via greater engagement with patients, consumers and shoppers can meet this emerging need.

X
Pharma and proactive, preventative healthcare: how to use the pharmacy channel
https://pharmaphorum.com/debates-insight-market-access/pharma-proactive-preventative-healthcare-use-pharmacy-channel/
 
When small becomes big: orphan medicines, advances, access and affordability

When small becomes big: orphan medicines, advances, access and affordability

Significant unmet need still remains in the rare disease market, only around 5% of rare diseases currently have an approved drug treatment. This represents a major opportunity for the pharmaceutical industry. Our webinar will assess the critical factors underpinning success in the rare disease space and provide a view into the future of market access and health technology assessments for orphan medicines – alongside the impact on R&D and clinical trials – in the context of Brexit negotiations.

X
When small becomes big: orphan medicines, advances, access and affordability
https://pharmaphorum.com/debates-insight-market-access/small-becomes-big-orphan-medicines-advances-access-affordability/
 
Unlocking the value of pharmacists to reach the right patients and consumers

Unlocking the value of pharmacists to reach the right patients and consumers

Pharmacists are highly trained healthcare professionals who have a deep understanding of medicines and daily contact with patients and consumers, putting them in a unique position in terms of being able to maximise the benefits that patients get from their medicines. However, healthcare systems and pharmaceutical companies frequently overlook this potential.

X
Unlocking the value of pharmacists to reach the right patients and consumers
https://pharmaphorum.com/debates-insight-sales-marketing/unlocking-value-pharmacists-reach-right-patients-consumers/
1 2 3
CONTINUE TO SITE >
X
Close in 10 seconds